abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb

這頁面沒有繁體中文版本,現以English顯示

文章

2007年4月26日

作者:
Lisa Sachs, public health & law intern, Interfaith Center on Corporate Responsibility

[PDF] Human Rights Challenges Facing Abbott Laboratories: Risks and recommendations

Abbott has been criticized by consumers, investors, medical professionals, human rights activists, and governments for failing to ensure universal access to essential medicines, thereby violating the universal right to health. This memo focuses on Abbott’s responsibility with respect to the universal right to health and how Abbott has addressed, is addressing and should address this universal human right.